HIRA and cancer: Accordingly, dysregulation of HIRA or DAXX complexes is observed in various types of cancers, such as breast, lung, prostate, colorectal, glioma, pancreatic, leukemia, prostate, gastric, ovarian, and chondrosarcoma.